Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

🩺 Protocol Summary

This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.

Primary Research Facility: M D Anderson Cancer Center (Houston, Texas)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Prostate Cancer?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged 65 Years or older? • (Protocol specifies male participants only)

🔍 Protocol Specified Minimum Age: 65 Years

Able to attend required clinic visits at M D Anderson Cancer Center (Houston, Texas)?

🔍 Logistical Requirement: Site at M D Anderson Cancer Center

📍 Primary Site Map

Site: M D Anderson Cancer Center — Houston, Texas

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.